CD1: antigen presentation and T cell function. Annu Rev Immunol 2004; 22:817–90. , .
Toward an understanding of NKT cell biology. Annu Rev Immunol 2005; 23:877–900. .
The biology of NKT cells. Annu Rev Immunol 2007; 25:297–336. , , .
CD4pos, NK1.1pos T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3. J Exp Med 1994; 179:1285–95. , .
et al. Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 2005; 434:525–9. , ,
et al. Recognition of bacterial glycosphingolipids by natural killer T cells. Nature 2005; 434:520–5. , ,
Cell wall glycoshingolipids of Sphingomonas paucimobilis are CD1d-specific ligands for NKT cells. Eur J Immunol 2005; 35:1692–701. , , , .
et al. Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria. Nat Immunol 2006; 7:978–86. , ,
Mechanism of CD1d-restricted natural killer T cell activation during microbial infection. Nat Immunol 2003; 4:1230–7. , , , , .
Invariant NKT cells amplify the innate immune response to lipopolysaccharide. J Immunol 2007; 178:2706–13. , .
et al. Activation of invariant NKT cells by Toll-like receptor 9-stimulated dendritic cells requires type I interferon and charged glycosphingolipids. Immunity 2007; 27:597–609. , ,
et al. Modulation of human natural killer T cell ligands on TLR-mediated antigen-presenting cell activation. Proc Natl Acad Sci USA 2007; 104:20490–5. , ,
et al. Monocyte chemoatrractant protein-1-dependent increase of Vα14 NKT cells in lungs and their role in Th1 response and host defense in cryptococcul infection. J Immunol 2001; 167:6525–32. , ,
et al. CD4+ Vα 14 NKT cells play a crucial role in an early stage of protective immunity against infection with Leishmania major. Int Immunol 2000; 12:1267–74. , ,
Rapid NKT cell responses are self-terminating during the course of microbial infection. J Immunol 2008; 181:2292–302. , , , .
et al. Anti-inflammatory role for Vα14 NK T cells in Mycobacterium bovis Bacillus Calmette–Guérin-infected mice. J Immunol 2003; 171:1961–8. , ,
The role of CD1d-restricted NK T lymphocytes in the immune response to oral infection with Salmonella typhimurium. Eur J Immuonol 2005; 35:2100–9. , , , , .
et al. Critical role of Vα14+ natural killer T cells in the innate phase of host protection against Streptococcus pneumoniae infection. Eur J Immunol 2003; 33:3322–30. , ,
et al. Role of interferon-γ in Vα14+ natural killer T cell-mediated host defense against Streptococcus pneumoniae infection in murine lungs. Microbes Infect 2007; 9:364–74. , ,
Cutting edge: CD1d deficiency impairs murine host defense against the spirochete, Borrelia burgdorferi. J Immunol 2000; 165:4797–801. , , , .
et al. Activation of natural killer T cells by α-galactosylceramide impairs DNA vaccine-induced protective immunity against Trypanosoma crusi. Infect Immun 2003; 71:1234–41. , ,
Critical proinflammatory and anti-inflammatory functions of different subsets of CD1d-restricted natural killer T cells during Trypanosoma cruzi infection. Infect Immun 2005; 73:181–92. , , , , .
et al. Different tumor surveillance by natural killer (NK) and NKT cells. J Exp Med 2000; 191:661–8. , ,
et al. Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. Nat Med 2003; 9:582–8. , ,
NKT cells and autoimmune diseases: unraveling the complexity. Curr Top Miocrobiol Immunol 2007; 314:251–67. , .
CD1d-dependent activation of NKT cells aggravated atherosclerosis. J Exp Med 2004; 199:417–22. , , , , , , .
et al. Natural killer T cells accelerate atherogenesis in mice. Blood 2004; 104:2051–9. , ,
et al. Quantitative and qualitative differences in proatherogenic NKT cells in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2004; 24:2351–7. , ,
Transient role for CD1d-restricted natural killer T cells in the formation of arherosclerotic lesions. Arterioscler Thromb Vasc Biol 2005; 25:628–32. , , .
Increased interleukin 4 and immunoglobulin E production in transgenic mice overexpressing NK1 T cells. J Exp Med 1996; 184:1285–93. , , .
et al. Innate immune response to encephalomyocarditis virus infection mediated by CD1d. Immunology 2003; 110:519–26. , ,
et al. Murine CD1d-restricted T cell recognition of cellular lipids. Immunity 2000; 12:211–21. , ,
et al. Glycolipid antigen drives rapid expansion and sustained cytokine production by NK T cells. J Immunol 2003; 171:4020–7. , ,
The response of natural killer T cells to glycolipid antigens is characterized by surface receptor down-modulation and expansion. Proc Natl Acad Sci USA 2003; 100:10913–8. , , , , , , , .
et al. Down-regulation of the invariant Vα14 antigen receptor in NKT cells upon activation. Int Immunol 2004; 16:241–7. , ,
Glycolipid antigen induces long-term natural killer T cell anergy in mice. J Clin Invest 2005; 115:2572–83. , , , , , , , .
et al. NKT cell stimulation with glicolipid antigen in vivo: costimulation-dependent expansion, Bim-dependent contraction, and hyporesponsiveness to further antigenic challenge. J Immunol 2005; 175:3092–3101. , ,
Impact of bacteria on the phenotype, function and therapeutic activities of invariant NKT cells in mice. J Clin Invest 2008; 118:2301–15. , , , , , .
Natural killer T cells reactive to a single glycolipid exhibit a highly diverse T cell receptor β repertoire and small clone size. Proc Natl Acad Sci USA 2001; 98:12636–41. , , , , , .
Mechanisms imposing the Vβ bias of Vα14 natural killer T cells and consequences for microbial glycolipid recognition. J Exp Med 2006; 203:1197–207. , , , , .
NKT cells direct monocytes into a DC differentiation pathway. J Leukoc Biol 2007; 81:1224–35. , , , , , .
et al. Identification of an IL-17-producing NK1.1neg iNKT cell population involved in airway neutrophilia. J Exp Med 2007; 204:995–1001. , ,
NKT cells constitutively express IL-23 receptor and RORγt and rapidly produce IL-17 upon receptor ligation in an IL-6-independent fashion. J Immunol 2008; 180:5167–71. , , , , , , , .
et al. Diverse cytokine production by NKT cell subsets and identification of an IL-17-producing CD4−NK1.1− NKT cell population. Proc Natl Acad Sci U S A 2008; 105:11287–92. , ,
NK T cell precursors exhibit differential cytokine regulation and require Itk for efficient maturation. J Immunol 2002; 169:2397–406. , .
Control of NKT cell differentiation by tissue-specific microenvironments. J Immunol 2003; 171:5913–20. , , , , , , .
et al. DX5/CD49b-positive T cells are not synonymous with CD1d-dependent NKT cells. J Immunol 2005; 175:4416–25. , ,
Regulation of NKT cells by Ly49: analysis of primary NKT cells and generation of NKT cell line. J Immunol 2001; 167:4180–6. , , , .
Generation and sustained expansion of mouse spleen invariant NKT cell lines with preserved cytokine releasing capacity. J Immunol Methods 2007; 322:70–81. , , , , , , .
Influence of the TCR Vβ domain on the avidity of CD1d:α-galactosylceramide binding by invariant Va14 NKT cells. J Immunol 2003; 170:5815–9. , , , .
et al. Distinct homeostatic requirements of CD4+ and CD4− subsets of Vα24-invariant natural killer T cells in humans. Blood 2004; 104:4150–6. , ,